Literature DB >> 12742283

C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms.

Juan Cosín-Sales1, Carmine Pizzi, Sue Brown, Juan Carlos Kaski.   

Abstract

OBJECTIVES: We sought to investigate the relationship among C-reactive protein (hs-CRP), clinical characteristics, exercise stress test responses, and ST-segment changes during daily life in patients with typical chest pain and normal coronary angiograms (CPNCA).
BACKGROUND: Patients with CPNCA have coronary microvascular endothelial dysfunction and myocardial ischemia. Elevated hs-CRP levels have been related to atherogenesis and endothelial dysfunction. The relationship between hs-CRP and disease activity has not been previously investigated in CPNCA patients.
METHODS: We studied 137 consecutive CPNCA patients (mean age, 57 +/- 9; 33 men). All completed standardized angina questionnaires, underwent exercise stress testing, 24-h ambulatory electrocardiogram (ECG) monitoring (Holter), and hs-CRP measurements at study entry.
RESULTS: C-reactive protein levels (mg/l) were higher in patients with frequent (2.9 +/- 3.3) and prolonged (3.9 +/- 4.1) chest pain episodes, and in those with ST-segment depression on exercise testing (2.6 +/- 2.8) and Holter monitoring (3.4 +/- 3.1) compared with patients with occasional (1.3 +/- 1.2; p = 0.002) or shorter chest pain (1.5 +/- 1.3; p < 0.001) episodes, negative exercise stress testing (1.1 +/- 1.1; p < 0.001), and no ST-segment shifts on Holter monitoring (0.9 +/- 0.7; p < 0.001). Moreover, we found a correlation between hs-CRP concentration and number of ischemic episodes during Holter monitoring (r = 0.65; p < 0.001) and with the magnitude of ST-segment depression on exercise testing (r = -0.43; p < 0.001). The hs-CRP was the only independent variable (multivariate logistic regression) capable of predicting positive findings on Holter monitoring (odds ratio [OR], 3.8; confidence interval [CI], 2.3 to 6.2) and exercise testing (OR, 1.7; CI, 1.2 to 2.2).
CONCLUSIONS: The hs-CRP correlates with symptoms and ECG markers of myocardial ischemia in CPNCA patients. Whether hs-CRP is related to the pathogenesis of angina in these patients deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742283     DOI: 10.1016/s0735-1097(03)00243-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  34 in total

1.  C reactive protein and microvascular function.

Authors:  F Tomai
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 2.  Angina pectoris and normal coronary arteries: cardiac syndrome X.

Authors:  Filippo Crea; Gaetano A Lanza
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

Review 3.  Cardiac syndrome X: a critical overview and future perspectives.

Authors:  G A Lanza
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

4.  Effects of nebivolol therapy on endothelial functions in cardiac syndrome X.

Authors:  Fatma Kayaalti; Nihat Kalay; Emrullah Basar; Ertuğrul Mavili; Mustafa Duran; Ibrahim Ozdogru; Ali Dogan; Mehmet Tugrul Inanc; Mehmet Gungor Kaya; Ramazan Topsakal; Abdurrahman Oguzhan
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

5.  Microvascular dysfunction in cardiac syndrome X: the role of inflammation.

Authors:  Ramón Arroyo-Espliguero; Juan Carlos Kaski
Journal:  CMAJ       Date:  2006-06-20       Impact factor: 8.262

6.  Receptor for advanced glycation end products gene polymorphisms in cardiac syndrome X.

Authors:  Burak Önal; Deniz Özen; Bülent Demir; Ahmet G Akkan; Sibel Özyazgan
Journal:  Biomed Rep       Date:  2019-07-22

Review 7.  Etiopathogenesis of microvascular angina: caveats in our knowledge.

Authors:  S R Mittal
Journal:  Indian Heart J       Date:  2014-11-04

Review 8.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.

Authors:  C Noel Bairey Merz; Carl J Pepine; Mary Norine Walsh; Jerome L Fleg
Journal:  Circulation       Date:  2017-03-14       Impact factor: 29.690

9.  Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X.

Authors:  Po-Hsun Huang; Yung-Hsiang Chen; Yuh-Lien Chen; Tao-Cheng Wu; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Heart       Date:  2007-05-08       Impact factor: 5.994

Review 10.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.